[1]
“Longitudinal Monitoring of Apparent Diffusion Coefficient (ADC) In Patients with Prostate Cancer Undergoing MR-guided Radiotherapy on an MR-Linac at 1.5 T: A Prospective Feasibility Study”, Radiol Oncol, vol. 57, no. 2, pp. 184–190, Jun. 2023, Accessed: Sep. 22, 2026. Available: https://radioloncol.com/index.php/ro/article/view/4039